This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans

This study has been completed.
VA Connecticut Healthcare System
Information provided by (Responsible Party):
Yale University Identifier:
First received: February 4, 2008
Last updated: July 7, 2014
Last verified: July 2014
The purpose of this study is to characterize the interactive effects of acute intravenous (IV) alcohol and nicotine administration in male and female smokers and nonsmokers who use alcohol.

Condition Intervention Phase
Alcohol Consumption Tobacco Use Drug: Nicotine Drug: Ethanol Early Phase 1

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Official Title: Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans

Resource links provided by NLM:

Further study details as provided by Yale University:

Primary Outcome Measures:
  • Behavioral and Cognitive Measures [ Time Frame: Baseline and Test Day ]

Enrollment: 18
Study Start Date: January 2007
Study Completion Date: June 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Three test days, within-subject design.
Drug: Nicotine
1.0 microg/kg/min IV x 10 minutes
Drug: Ethanol


Ages Eligible for Study:   21 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Male or Female, 21 to 50 years old.

Exclusion Criteria:

  • Alcohol or Nicotine Naive
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00616746

United States, Connecticut
VA Connecticut Healthcare System, West Haven Campus
West Haven, Connecticut, United States, 06516
Sponsors and Collaborators
Yale University
VA Connecticut Healthcare System
Principal Investigator: Deepak C D'Souza, M.D. Yale University
  More Information

Responsible Party: Yale University Identifier: NCT00616746     History of Changes
Other Study ID Numbers: 0607001614
Study First Received: February 4, 2008
Last Updated: July 7, 2014

Keywords provided by Yale University:
Alcohol, nicotine

Additional relevant MeSH terms:
Alcohol Drinking
Drinking Behavior
Anti-Infective Agents, Local
Anti-Infective Agents
Central Nervous System Depressants
Physiological Effects of Drugs
Ganglionic Stimulants
Autonomic Agents
Peripheral Nervous System Agents
Nicotinic Agonists
Cholinergic Agonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action processed this record on August 23, 2017